Osteoporosis - The Silent Health Killer
World Osteoporosis Day is celebrated on 20 October each year and was officially established by the World Health Organisation (WHO) in 1998, with the aim of spreading awareness of osteoporosis and preventing and reducing the incidence of osteoporotic fractures. 2024 World Osteoporosis Day is themed ‘Say no to fragile bones’, encouraging people of all ages to pay attention to and protect their bone health.
Osteoporosis is a systemic bone disease caused by a variety of factors, mainly characterised by a decrease in bone density and quality, and damage to the bone microstructure, resulting in an increase in bone fragility and an increased susceptibility to fracture. Osteoporosis is mainly classified into two categories: primary and secondary. Primary osteoporosis is subdivided into postmenopausal osteoporosis (type I), senile osteoporosis (type II) and idiopathic osteoporosis. Osteoporosis is closely related to sarcopenia and the two often occur together, increasing the risk of falls and fractures.
The causes of osteoporosis are complex and varied, including genetic factors, changes in hormone levels, lifestyle habits and the effects of disease. According to statistics, there are currently about 200 million osteoporosis patients worldwide, and among people over 50 years old, the prevalence of osteoporosis in women is about 33%, while that in men is about 20%. With aging becoming more and more serious, the prevalence of osteoporosis tends to increase year by year. Therefore, it is crucial to raise the awareness of osteoporosis and strengthen the research and prevention of osteoporosis.
CUSABIO has long been committed to providing researchers with high-quality proteins, antibodies, ELISA kits and other tools for scientific research reagents, and has compiled a series of popular targets related to osteoporosis research and related reagent products listed below for your selection:
Popular Research Targets:
● Recombinant Proteins Relevant to Osteoporosis Research
● Antibodies Relevant to Osteoporosis Research
| Antibody Type |
Product Name |
Species Reactivity |
Tested Applications |
Code |
| Polyclonal Antibody |
BTK Antibody |
Human, Mouse |
ELISA, WB, IHC, IF |
CSB-PA002867LA01HU |
| Polyclonal Antibody |
Phospho-BTK (Y223) Antibody |
Human, Mouse, Rat |
ELISA, WB |
CSB-PA000638 |
| Polyclonal Antibody |
BTK Antibody |
Human, Mouse, Rat |
ELISA, WB |
CSB-PA005537 |
| Polyclonal Antibody |
Phospho-BTK (Y551) Antibody |
Human, Mouse, Rat |
ELISA, WB |
CSB-PA000639 |
| Polyclonal Antibody |
BTK Antibody |
Human, Mouse, Rat, Monkey |
ELISA, WB, IHC |
CSB-PA001066 |
| Polyclonal Antibody |
BTK Antibody |
Human, Mouse, Rat |
ELISA, WB |
CSB-PA002867GA01HU |
| Polyclonal Antibody |
Phospho-BTK (Tyr223) Antibody |
Human, Mouse, Rat |
ELISA, WB |
CSB-PA142166 |
| Recombinant Antibody |
BTK Recombinant Monoclonal Antibody |
Human |
ELISA, IHC |
CSB-RA553167A0HU |
| Monoclonal Antibody |
CD19 Monoclonal Antibody |
Human |
ELISA, WB, IHC, IF, FC |
CSB-MA004888A0m |
| Monoclonal Antibody |
CD19 Monoclonal Antibody |
Human |
ELISA, WB, IHC, FC |
CSB-MA004888A1m |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,APC Conjugated |
Human |
ELISA, IF, FC |
CSB-MA195220 |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,Biotin Conjugated |
Human |
ELISA, IF, FC |
CSB-MA899608 |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,FITC Conjugated |
Human |
ELISA, IF, FC |
CSB-MA047662 |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,PE Conjugated |
Human |
ELISA, IF, FC |
CSB-MA036486 |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,PE-Cy5 Conjugated |
Human |
ELISA, IF, FC |
CSB-MA281869 |
| Monoclonal Antibody |
CD19 Monoclonal Antibody,Purified |
Human |
ELISA, FC |
CSB-MA798261 |
| Polyclonal Antibody |
CD19 Antibody |
Human, Mouse, Monkey |
ELISA, WB |
CSB-PA001431 |
| Polyclonal Antibody |
Phospho-CD19 (Y531) Antibody |
Human, Mouse, Monkey |
ELISA, WB |
CSB-PA070286 |
| Polyclonal Antibody |
CD19 Antibody |
Human |
ELISA, WB |
CSB-PA006159 |
| Polyclonal Antibody |
CD19 (Ab-531) Antibody |
Human, Mouse |
ELISA, WB |
CSB-PA253616 |
● ELISA Kits Relevant to Osteoporosis Research
| Target |
Product Name |
Sample Types |
Detection Range |
Code |
| IL6 |
Human Interleukin 6,IL-6 ELISA KIT |
serum, plasma, cell culture supernates, tissue homogenates, urine |
7.8 pg/mL-500 pg/mL |
CSB-E04638h |
| IL6 |
Mouse Interleukin 6,IL-6 ELISA KIT |
|
Request Information |
CSB-E04639m |
| IL6 |
Rat Interleukin 6,IL-6 ELISA KIT |
|
Request Information |
CSB-E04640r |
| INS |
Rat Insulin,INS ELISA KIT |
serum, plasma, cell culture supernates |
15.6 nIU/mL-1000 nIU/mL |
CSB-E05070r |
| INS |
Mouse Insulin,INS ELISA KIT |
serum, plasma, cell culture supernates, tissue homogenates, cell lysates |
15.6 nIU/mL-1000 nIU/mL |
CSB-E05071m |
| NFKB1 |
Rat Nuclear factor-kappa B(NF-κB) ELISA KIT |
serum, plasma, tissue homogenates |
1.56 pg/mL-100 pg/mL |
CSB-E13148r |
| TNF |
Human Tumor necrosis factor α,TNF-α ELISA KIT |
serum, plasma, cell culture supernates, tissue homogenates, cell lysates |
7.8 pg/mL-500 pg/mL |
CSB-E04740h |
| TNF |
Mouse Tumor necrosis factor α,TNF-α ELISA KIT |
serum, plasma, cell culture supernates, tissue homogenates |
15.6 pg/ml-1000 pg/ml |
CSB-E04741m |
| TNF |
Rat TNF-α ELISA KIT |
serum, plasma, cell culture supernates, tissue homogenates |
6.25 pg/mL-400 pg/mL |
CSB-E11987r |
